Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

STERIS plc stock price, quote, forecast and news

STE
IE00BFY8C754
A2PGLV

Price

245.50
Today +/-
+5.15
Today %
+2.34 %
P

STERIS plc stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the STERIS plc stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the STERIS plc stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the STERIS plc stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze STERIS plc's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

STERIS plc Stock Price History

DateSTERIS plc Price
9/9/2024245.50 undefined
9/6/2024239.82 undefined
9/5/2024239.05 undefined
9/4/2024240.41 undefined
9/3/2024243.15 undefined
8/30/2024241.10 undefined
8/29/2024237.71 undefined
8/28/2024237.07 undefined
8/27/2024236.43 undefined
8/26/2024235.07 undefined
8/23/2024236.01 undefined
8/22/2024234.14 undefined
8/21/2024234.38 undefined
8/20/2024233.27 undefined
8/19/2024233.57 undefined
8/16/2024232.34 undefined
8/15/2024230.32 undefined
8/14/2024232.79 undefined
8/13/2024233.79 undefined
8/12/2024233.94 undefined

STERIS plc Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into STERIS plc, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by STERIS plc from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects STERIS plc’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of STERIS plc. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into STERIS plc’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing STERIS plc’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on STERIS plc’s growth potential.

STERIS plc Revenue, EBIT and net profit per share

DateSTERIS plc RevenueSTERIS plc EBITSTERIS plc Net Income
2029e7.25 B undefined0 undefined1.24 B undefined
2028e6.81 B undefined0 undefined1.12 B undefined
2027e6.27 B undefined1.44 B undefined1.08 B undefined
2026e5.9 B undefined1.37 B undefined1 B undefined
2025e5.55 B undefined1.27 B undefined912.52 M undefined
20245.14 B undefined887.69 M undefined378.24 M undefined
20234.96 B undefined783.4 M undefined107 M undefined
20224.59 B undefined425.6 M undefined243.9 M undefined
20213.11 B undefined545.5 M undefined397.4 M undefined
20203.03 B undefined537.7 M undefined407.7 M undefined
20192.78 B undefined458.2 M undefined303.7 M undefined
20182.62 B undefined401.4 M undefined290.9 M undefined
20172.61 B undefined286.7 M undefined110 M undefined
20162.24 B undefined212.8 M undefined110.8 M undefined
20151.85 B undefined228.3 M undefined135.1 M undefined
20141.62 B undefined221.2 M undefined129.4 M undefined
20131.5 B undefined242.4 M undefined160 M undefined
20121.41 B undefined223 M undefined136.1 M undefined
20111.21 B undefined106.3 M undefined51.3 M undefined
20101.26 B undefined208.1 M undefined128.5 M undefined
20091.3 B undefined179 M undefined110.7 M undefined
20081.27 B undefined139 M undefined77.1 M undefined
20071.2 B undefined144.3 M undefined82.2 M undefined
20061.16 B undefined135 M undefined70.3 M undefined
20051.08 B undefined141.3 M undefined86 M undefined

STERIS plc Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)EBIT (B)EBIT MARGIN (%)NET INCOME (B)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (M)DOCUMENTS
199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025e2026e2027e2028e2029e
00.010.010.030.050.550.530.590.720.80.760.80.870.971.031.081.161.21.271.31.261.211.411.51.621.852.242.612.622.783.033.114.594.965.145.555.96.276.817.25
-166.6750.00116.6773.081,111.11-2.029.9322.4910.85-4.645.268.2512.246.074.857.313.195.682.61-3.16-3.9816.496.768.0614.0620.9716.710.316.188.912.5447.578.113.658.046.316.248.586.52
33.3362.5058.3357.6960.0037.4337.8339.3545.0646.1739.2138.8840.9941.9842.9742.6541.7241.1040.3240.5242.8036.9540.4041.3740.0141.8439.9939.2841.6842.2443.5643.2243.9743.5543.17-----
00.010.010.020.030.20.20.230.320.370.30.310.360.410.440.460.480.490.510.530.540.450.570.620.650.770.91.031.091.181.321.342.022.162.2200000
-00000.010.070.070.080.110.140.030.020.080.130.130.140.140.140.140.180.210.110.220.240.220.230.210.290.40.460.540.550.430.780.891.271.371.4400
-66.67--7.6917.7811.9312.9214.3115.5817.063.823.009.2412.8612.4213.0411.6412.0310.9913.7916.558.7815.8616.1213.6312.329.4710.9515.3116.4617.7217.549.2715.8017.2622.8123.1722.95--
-00000.01-0.040.04-0.030.070.080.0100.050.080.090.090.070.080.080.110.130.050.140.160.130.140.110.110.290.30.410.40.240.110.380.9111.081.121.24
----200.00-716.67-208.11-175.00-316.6729.23-88.10-90.004,500.0071.7418.99-8.51-18.6017.14-6.1042.8616.36-60.16166.6717.65-19.384.65-18.52-163.644.4834.32-2.46-38.79-55.97253.27141.279.877.583.5310.66
----------------------------------------
----------------------------------------
21.923.224.732.16667.169.767.470.270.668.66970.670.970.77068.965.76459.459.460.15958.859.76071.286.185.785.585.685.998.3100.299.3600000
----------------------------------------
Details

Keystats

ⓘ

Revenue and Growth

The STERIS plc Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the STERIS plc is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (B)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (B)TANGIBLE ASSETS (B)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (B)GOODWILL (B)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (B)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (B)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (B)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (B)DEBT (B)TOTAL CAPITAL (B)
1991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024
                                                                   
01202015150241724352512268024735252154215193151142153168249283202221320221348208207.02
000.010.010.020.130.160.20.230.210.20.20.210.250.250.240.250.250.240.220.270.280.280.310.330.470.480.530.570.590.610.80.931.01
0000000000000000000000000000000000
11244747983991158278909898112132147130121167158144155161193198206208264315575695674.54
011231534364030323027285333506430257363515367595354605467157179979.25
00.010.030.040.040.370.30.340.390.390.340.320.360.460.420.460.490.510.550.580.710.650.610.680.720.971.020.991.051.221.211.882.012.87
00000.010.090.10.210.260.310.310.330.350.370.410.40.390.390.350.350.370.390.430.450.491.060.921.011.031.241.391.741.91.94
0000000000000000000000000000000000
0000000000000000000000000000000000
000000.020.010.010.0100.010.010.010.020.050.050.050.050.030.030.030.030.220.230.861.120.730.730.610.570.93.332.962.12
000000.080.110.160.20.20.180.180.180.220.30.280.280.290.270.280.290.310.490.5202.162.232.432.322.363.034.43.884.07
000112717935363271338103230111023303539605253717866.2
0000.010.020.230.240.390.470.510.510.530.540.610.770.730.730.730.660.660.720.751.151.211.384.373.914.214.024.225.369.558.818.19
00.010.030.040.050.590.540.730.870.90.850.840.91.071.191.191.211.241.221.241.431.411.761.892.15.354.925.25.075.446.5811.4210.8211.06
                                                                   
0.010.010.030.030.030.210.230.230.220.20.20.220.220.230.210.140.230.230.230.240.240.240.240.250.272.152.092.0521.9824.744.494.54
0000000000000000000000000000000000
-0.01-0.01-000.010.10.070.140.220.230.230.280.360.450.540.60.670.720.810.80.820.911.031.111.190.940.951.151.341.661.9421.912.09
00000-6-6-7-7-8-11-14-1246-8533-15133513-44-68-67-24110-160-235-61-210-321-328.66
000000000000000000-1000011-102000000
000.030.040.040.30.30.360.440.420.430.490.570.680.760.730.90.991.031.051.091.171.271.361.393.022.83.213.183.413.886.536.086.3
1224532393747514857736864877676696691837910299140133136153149157226280251.72
1124510411712610810311092101114117113122106108771981227981101121108126183229266328299362.25
01000000000201523720194825545573607183140140136129125155226224231.22
0000000000000000000000000000000000
00000002221224521100000000000001436085.94
244810136156165157156159171191188223222218231202197344278218254283401381398465503578923863931.13
000000.10.040.150.220.270.210.120.060.110.10.110.10.180.210.210.210.210.490.490.621.571.481.321.181.151.652.953.023.12
000000003911191830373518618212743455972255172160151164237781618479.69
0000150535149494450566067879911869565752583947848310988204218231237217.37
000000.150.090.20.270.330.260.180.130.20.210.240.220.30.30.290.290.310.60.590.741.911.731.591.421.522.113.963.873.82
0000.010.010.290.250.370.430.480.420.360.330.390.430.460.440.530.50.480.640.580.810.851.022.312.111.981.892.022.684.884.744.75
00.010.030.040.060.590.540.730.870.90.850.840.891.071.191.191.331.521.531.531.731.752.082.212.425.334.915.195.075.436.5711.4110.8111.05
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of STERIS plc provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand STERIS plc's financial health and stability.

Assets

STERIS plc's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that STERIS plc must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of STERIS plc after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into STERIS plc's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
1990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
-20026-3740-3065841014679948670827711012851136160129135111110291305407396242105
00000181918243339564646485157606258565462697591143188178225197219553552
00001-167-1271441124713-7-10-1062-43222315-4031-24-694-106-185
00-1-2-4530-14-79-66233730-9-26-1234-48-1-12735-75-30-2630-20-57-599-4919-149-250
0000-150155-53-15612410712140183011142783516993294976202573
000009465817189215576101312121401937424844383684108
0000081217272098437462948775346576151380526078856492109138254
-20-10268691612697510214213312914816295143167225117149227209246254424457539590689684756
000-1-2-19-15-20-39-77-77-51-65-58-66-55-51-49-57-40-44-77-66-87-86-85-126-172-165-189-214-239-287-362
000-1-21-5-17-88-119-118-85-50-68-58-108-187-36-43-51-25-42-97-101-487-148-283-729-104-203-213-319-1,154-666-383
0000-1814-2-67-80-41-80-20-41-1311455151-19-34-399-62-198-60368-38-23-105-914-379-21
0000000000000000000000000000000000
00000-54-1-661056846-64-92-58-57-67-1478300002821129626-75-193-112-26484372-6
10320161016-3-12-2436-496-12-72-51-162-4613-17-5115-9-2-3-92-55-68-1612-45-306
103191-4622-451045621-61-85-6238-19-76-75-95-28-127-47-88254-5469560-267-356-294-163345115-498
000001125200000-10012622102-41-6-4-12-17-47-2
000-1000000000000-10-11-14-17-144-33-38-43-48-53-65-93-102-112-123-133-163-183
-10018-171976-120-3611-10-121360-5649-20010260-21-42-810148134-811999-99127-140
-2.5-0.8-2.3-0.30.249.154.7-4.2-27.2-8.3-1.851.376.374.762.493.411146.786.4126.5180.940.382.7140.4123.2160.7128.3251.2292.1349.8376.1450.3397.2394.9
0000000000000000000000000000000000

STERIS plc stock margins

The STERIS plc margin analysis displays the gross margin, EBIT margin, as well as the profit margin of STERIS plc. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for STERIS plc.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the STERIS plc's sales revenue. A higher gross margin percentage indicates that the STERIS plc retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the STERIS plc's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the STERIS plc's total revenue generated. When comparing the revenue margin year over year, investors can gauge the STERIS plc's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the STERIS plc. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the STERIS plc's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

STERIS plc Margin History

STERIS plc Gross marginSTERIS plc Profit marginSTERIS plc EBIT marginSTERIS plc Profit margin
2029e43.17 %0 %17.03 %
2028e43.17 %0 %16.4 %
2027e43.17 %22.95 %17.2 %
2026e43.17 %23.17 %16.99 %
2025e43.17 %22.81 %16.44 %
202443.17 %17.27 %7.36 %
202343.56 %15.8 %2.16 %
202243.98 %9.28 %5.32 %
202143.22 %17.55 %12.79 %
202043.55 %17.74 %13.45 %
201942.23 %16.47 %10.92 %
201841.71 %15.32 %11.1 %
201739.28 %10.97 %4.21 %
201640 %9.51 %4.95 %
201541.85 %12.34 %7.3 %
201440.04 %13.63 %7.98 %
201341.37 %16.14 %10.65 %
201240.41 %15.85 %9.67 %
201136.96 %8.8 %4.25 %
201042.83 %16.55 %10.22 %
200940.56 %13.79 %8.53 %
200840.36 %10.99 %6.09 %
200741.11 %12.05 %6.86 %
200641.73 %11.63 %6.06 %
200542.7 %13.06 %7.95 %

STERIS plc Stock Sales Revenue, EBIT, Earnings per Share

The STERIS plc earnings per share therefore indicates how much revenue STERIS plc has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue STERIS plc earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates STERIS plc's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of STERIS plc’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating STERIS plc's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

STERIS plc Revenue, EBIT and net profit per share

DateSTERIS plc Sales per ShareSTERIS plc EBIT per shareSTERIS plc Earnings per Share
2029e73.53 undefined0 undefined12.52 undefined
2028e69.02 undefined0 undefined11.32 undefined
2027e63.57 undefined0 undefined10.93 undefined
2026e59.84 undefined0 undefined10.17 undefined
2025e56.29 undefined0 undefined9.25 undefined
202451.72 undefined8.93 undefined3.81 undefined
202349.48 undefined7.82 undefined1.07 undefined
202246.64 undefined4.33 undefined2.48 undefined
202136.18 undefined6.35 undefined4.63 undefined
202035.41 undefined6.28 undefined4.76 undefined
201932.54 undefined5.36 undefined3.55 undefined
201830.57 undefined4.68 undefined3.39 undefined
201730.35 undefined3.33 undefined1.28 undefined
201631.44 undefined2.99 undefined1.56 undefined
201530.84 undefined3.81 undefined2.25 undefined
201427.17 undefined3.71 undefined2.17 undefined
201325.54 undefined4.12 undefined2.72 undefined
201223.84 undefined3.78 undefined2.31 undefined
201120.09 undefined1.77 undefined0.85 undefined
201021.17 undefined3.5 undefined2.16 undefined
200921.86 undefined3.01 undefined1.86 undefined
200819.77 undefined2.17 undefined1.2 undefined
200718.23 undefined2.2 undefined1.25 undefined
200616.84 undefined1.96 undefined1.02 undefined
200515.45 undefined2.02 undefined1.23 undefined

STERIS plc business model

Steris plc is a global provider of products and services in the field of sterilization and disinfection. The company was founded in the United States in 1985 and became an Irish company with headquarters in Dublin in 2015. Steris plc's business model is based on offering solutions for the sterilization and disinfection of medical devices, rooms, and instruments. The company offers a wide range of products and services, including machines and equipment, chemicals and consumables, as well as consulting and training services. Steris plc is divided into several business segments, each focused on specific customer needs. The Healthcare Products division provides solutions for hospitals and medical facilities, including cleaning and disinfecting agents, surgical instruments, and sterilization equipment. The Life Sciences division offers products and services for biotechnology, pharmaceutical, and medical device companies, such as cleaning and sterilization services that comply with FDA regulations. Another important area of Steris plc is Applied Sterilization Technologies, which offers customized solutions for customers in various industries. These range from sterilizing food and beverages to industrial applications such as sterilizing materials in the automotive industry. In addition to offering products and services, Steris plc also specializes in consulting and training for customers. The company provides a wide range of training and seminars to ensure optimal use of sterilization and disinfection products and maximize safety and efficiency. One of Steris plc's most well-known products is the "STERIS V-PRO" system. This system is an automated sterilizer that allows for rapid sterilization of medical instruments and devices. Unlike traditional sterilization methods, this system uses high-energy waves for sterilization, making it possible to sterilize sensitive instruments and materials that may not be possible with conventional methods. Another product of Steris plc is the "SYSTEM 1" sterilization process, used for the sterilization of flexible endoscopes. This process is particularly efficient and effective, sterilizing the endoscopes quickly and thoroughly without causing damage during the process. Steris plc is a pioneer in the field of sterilization and disinfection and has established itself as a leading provider in this field. The company aims to develop innovative solutions to help customers worldwide meet their sterilization and disinfection requirements optimally. STERIS plc is one of the most popular companies on Eulerpool.com.

STERIS plc SWOT Analysis

Strengths

  • Strong market presence and leading position in the healthcare industry.
  • Diversified product portfolio offering a wide range of solutions for infection prevention, surgical equipment, and sterilization services.
  • Robust research and development capabilities enabling innovation and technological advancements.
  • Strong distribution network and global reach, allowing access to a large customer base.
  • Established brand reputation for quality and reliability.
  • Strong financial performance and stability, with consistent revenue growth and profitability.
  • Well-established partnerships and collaborations with healthcare providers and institutions.

Weaknesses

  • Reliance on a single industry, healthcare, making the company vulnerable to fluctuations in the sector.
  • Limited geographical diversification, with a significant portion of revenue generated from North America.
  • Limited presence in emerging markets, potentially missing out on growth opportunities.
  • Lack of pricing power due to intense competition in the market.
  • Challenges in integrating acquired businesses and managing potential cultural differences.

Opportunities

  • Growing global healthcare expenditure, providing opportunities for increased demand for Steris' products and services.
  • Expansion into emerging markets with a rising need for infection prevention and sterilization solutions.
  • Technological advancements and increased adoption of minimally invasive surgeries, creating demand for innovative surgical equipment.
  • Strategic acquisitions and partnerships to enhance product offerings and enter new market segments.
  • Increasing focus on patient safety and infection control, driving demand for Steris' products and services.
  • Potential growth in telemedicine and home healthcare, requiring specialized equipment and services.

Threats

  • Intense competition from both established players and new entrants in the healthcare industry.
  • Regulatory challenges and compliance requirements impacting product development and market access.
  • Economic downturns and budget constraints in the healthcare sector, leading to reduced spending on equipment and services.
  • Potential disruptions in the supply chain, affecting the availability of raw materials and components.
  • Shifts in customer preferences or negative perception regarding Steris' products or services.
  • Technological advancements or disruptive innovations that could render current solutions obsolete.

STERIS plc Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

STERIS plc historical P/E ratio, EBIT, and P/S ratio.

STERIS plc shares outstanding

The number of shares was STERIS plc in 2023 — This indicates how many shares 100.2 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue STERIS plc earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates STERIS plc's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of STERIS plc’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating STERIS plc's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

STERIS plc Stock splits

In STERIS plc's history, there have been no stock splits.

STERIS plc dividend history and estimates

In 2023, STERIS plc paid a dividend amounting to 1.98 USD. Dividend means that STERIS plc distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for STERIS plc provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify STERIS plc’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating STERIS plc's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

STERIS plc Dividend History

DateSTERIS plc Dividend
2029e1.64 undefined
2028e1.64 undefined
2027e1.64 undefined
2026e1.64 undefined
2025e1.64 undefined
20241.61 undefined
20231.98 undefined
20221.8 undefined
20211.66 undefined
20201.54 undefined
20191.42 undefined
20181.3 undefined
20171.18 undefined
20161.06 undefined
20150.96 undefined
20140.88 undefined
20130.8 undefined
20120.72 undefined
20110.64 undefined
20100.52 undefined
20090.41 undefined
20080.28 undefined
20070.22 undefined
20060.17 undefined
20050.12 undefined

STERIS plc dividend payout ratio

In 2023, STERIS plc had a payout ratio of 46.93%. The payout ratio indicates the percentage of the company's profits that STERIS plc distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for STERIS plc represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for STERIS plc could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate STERIS plc's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

STERIS plc Payout Ratio History

DateSTERIS plc Payout ratio
2029e53.25 %
2028e54.22 %
2027e53.61 %
2026e51.94 %
2025e57.1 %
202451.79 %
202346.93 %
202272.58 %
202135.85 %
202032.35 %
201940 %
201838.35 %
201792.19 %
201667.95 %
201542.67 %
201440.55 %
201329.41 %
201231.17 %
201175.29 %
201024.07 %
200922.04 %
200823.33 %
200717.6 %
200616.67 %
20059.84 %
Unfortunately, there are currently no price targets and forecasts available for STERIS plc.

STERIS plc latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/20242 2.14  (7.17 %)2025 Q1
3/31/20242.37 2.58  (8.7 %)2024 Q4
12/31/20232.19 2.22  (1.33 %)2024 Q3
9/30/20232.02 2.03  (0.3 %)2024 Q2
6/30/20231.89 2  (6.04 %)2024 Q1
3/31/20232.17 2.3  (5.99 %)2023 Q4
12/31/20222.22 2.02  (-8.83 %)2023 Q3
9/30/20222 1.99  (-0.69 %)2023 Q2
6/30/20221.93 1.9  (-1.77 %)2023 Q1
3/31/20222.04 2.04  (-0.12 %)2022 Q4
1
2
3
4
5
...
11

Eulerpool ESG Scorecard© for the STERIS plc stock

Eulerpool World ESG Rating (EESG©)

65/ 100

🌱 Environment

73

👫 Social

99

🏛️ Governance

24

Environment

Scope 1 - Direct Emissions
—
Scope 2 - Indirect emissions from purchased energy
—
Scope 3 - Indirect emissions within the value chain
—
Total CO₂ emissions
—
CO₂ reduction strategy
✅
Coal energy
❌
Nuclear power
❌
Animal experiments
❌
Fur & Leather
—
Pesticides
—
Palm Oil
—
Tobacco
❌
Genetically modified organisms
❌
Climate concept
—
Sustainable forestry
—
Recycling regulations
❌
Environmentally friendly packaging
✅
Hazardous substances
❌
Fuel consumption and efficiency
❌
Water consumption and efficiency
❌

Social

Percentage of female employees35.727
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content❌
Alcohol❌
Weapons—
Firearms
❌
Gambling❌
Military contracts❌
Human rights concept✅
Privacy concept—
Occupational health and safety✅
Catholic✅

Governance (Corporate Governance)

Environmental reporting✅
Stakeholder Engagement❌
Call Back Policies❌
Antitrust law❌

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

STERIS plc list of shareholders

%
Name
Stocks
Change
Date
6.01265 % BlackRock Institutional Trust Company, N.A.5,929,680282,30912/31/2023
5.56030 % MFS Investment Management5,483,57150,03812/31/2023
4.91800 % WCM Investment Management4,850,134-563,37512/31/2023
4.29775 % State Street Global Advisors (US)4,238,444101,83112/31/2023
3.67027 % APG Asset Management N.V.3,619,617319,11912/31/2023
2.88124 % Morgan Stanley Investment Management Ltd. (UK)2,841,481-85,80612/31/2023
2.21316 % Geode Capital Management, L.L.C.2,182,61656,15512/31/2023
2.03307 % Janus Henderson Investors2,005,018-91,04612/31/2023
11.98816 % The Vanguard Group, Inc.11,822,72653,32212/31/2023
1.50432 % T. Rowe Price Associates, Inc.1,483,55983,81612/31/2023
1
2
3
4
5
...
10

STERIS plc Executives and Management Board

Mr. Daniel Carestio50
STERIS plc President, Chief Executive Officer, Director (since 2015)
Compensation 7.74 M
Mr. Michael Tokich54
STERIS plc Chief Financial Officer, Senior Vice President
Compensation 2.89 M
Mr. John Zangerle56
STERIS plc Senior Vice President, General Counsel, Company Secretary
Compensation 2.26 M
Mr. Andrew Xilas58
STERIS plc Senior Vice President, General Manager - Dental
Compensation 1.85 M
Mr. Cary Majors48
STERIS plc Senior Vice President and President, Healthcare
Compensation 1.59 M
1
2
3
4

STERIS plc Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Thermon Group Holdings, Inc. Stock
Thermon Group Holdings, Inc.
SupplierCustomer0,750,81-0,31-0,27-0,110,45
Covetrus Inc Stock
Covetrus Inc
SupplierCustomer0,740,85-0,02-0,77-0,41
Prophecy International Holdings Limited Stock
Prophecy International Holdings Limited
SupplierCustomer0,280,68-0,17-0,060,76-
Austar Lifesciences Limited Stock
Austar Lifesciences Limited
SupplierCustomer-0,340,660,63-0,11-0,350,41
Stille AB Stock
Stille AB
SupplierCustomer-0,610,490,450,040,200,75
1

Most common questions regarding STERIS plc

What values and corporate philosophy does STERIS plc represent?

Steris plc is a global leader in infection prevention, sterilization, and surgical products and services. The values and corporate philosophy that define Steris plc revolve around their commitment to enhancing healthcare safety and improving the quality of patient care. The company focuses on delivering innovative solutions that enable healthcare professionals to create a safer environment for their patients. Steris plc consistently strives for excellence, constantly innovating and improving to meet the evolving needs of healthcare providers worldwide. With a strong emphasis on integrity, collaboration, and customer-centricity, Steris plc is dedicated to driving positive changes in healthcare practices and improving outcomes for patients.

In which countries and regions is STERIS plc primarily present?

Steris plc is primarily present in several countries and regions around the world. As a global company, Steris plc has a significant presence in the United States, where it is headquartered. It also operates in various regions including Europe, Asia, and Latin America. The company's international presence allows it to serve a diverse range of customers and expand its market reach. With a strong focus on providing innovative infection prevention and sterilization solutions, Steris plc continues to establish itself as a leader in the healthcare and life sciences industries worldwide.

What significant milestones has the company STERIS plc achieved?

Steris plc, a leading company in the medical technology field, has achieved several significant milestones over the years. One noteworthy accomplishment is the acquisition of Synergy Health, which allowed Steris plc to expand its product portfolio and strengthen its global presence. Additionally, the company made strides in research and development, launching innovative solutions such as the Sterrad NX and System 1E, which revolutionized sterilization practices in healthcare settings. Steris plc also gained recognition for its commitment to quality, receiving ISO 9001 certification for its manufacturing facilities. These milestones highlight Steris plc's dedication to delivering advanced and reliable medical technology solutions to its customers worldwide.

What is the history and background of the company STERIS plc?

Steris plc is a leading global provider of infection prevention and surgical products, services, and technologies. The company was founded in 1985 as Innovative Medical Technologies and later changed its name to Steris Corporation. In 2015, Steris Corporation merged with Synergy Health plc to become Steris plc. With a rich history spanning over three decades, Steris plc has been dedicated to advancing healthcare and related industries. The company offers a wide range of solutions, including sterilization systems, surgical tables, detergents, and disinfectants. Steris plc has established itself as a trusted name in the medical and life sciences sectors, constantly striving to enhance patient safety and improve healthcare outcomes.

Who are the main competitors of STERIS plc in the market?

The main competitors of Steris plc in the market include companies such as Johnson & Johnson, 3M Company, and Cantel Medical Corp. These companies operate in the same sector as Steris plc and provide similar products and services. However, Steris plc stands out due to its strong position in the market, diverse product portfolio, and robust customer base. With its innovative solutions and consistent focus on customer satisfaction, Steris plc continues to stay ahead of its competitors in the industry.

In which industries is STERIS plc primarily active?

Steris plc is primarily active in the healthcare industry. As a global leader, Steris provides innovative solutions and products focused on infection prevention, cleaning, and sterilization for healthcare facilities. With a wide range of offerings, Steris caters to hospitals, ambulatory surgical centers, pharmaceutical companies, and other healthcare institutions. By leveraging its expertise and advanced technologies, Steris aims to enhance patient safety, improve operational efficiency, and support healthcare professionals in delivering high-quality care.

What is the business model of STERIS plc?

The business model of Steris plc revolves around providing innovative and comprehensive solutions in the healthcare industry. As a global leader, Steris plc focuses on offering products and services that enhance infection prevention, sterilization, and surgical efficiency. With a wide range of offerings including equipment, consumables, and software solutions, Steris plc aims to improve patient outcomes and increase operational productivity for hospitals and healthcare facilities worldwide. Their dedication to advanced technologies and patient safety has earned them a strong reputation in the industry.

What is the P/E ratio of STERIS plc 2024?

The STERIS plc P/E ratio is 64.49.

What is the P/S ratio of STERIS plc 2024?

The STERIS plc P/S ratio is 4.75.

What is the AlleAktien quality score of STERIS plc?

The AlleAktien quality score for STERIS plc is 8/10.

What is the revenue of STERIS plc 2024?

The STERIS plc revenue is 5.14 B USD.

How high is the profit of STERIS plc 2024?

The STERIS plc profit is 378.24 M USD.

What is the business model of STERIS plc

Steris plc is a globally leading company in the field of sterilization and disinfection of medical instruments and facilities. Its business model is based on three main divisions: Healthcare Products, Healthcare Specialty Services, and Life Sciences. Steris offers a wide range of products and services to ensure effective sterilization and disinfection in the medical field. The company is committed to continuous improvement and innovation to meet customer needs. It also prioritizes sustainability and works closely with customers to develop tailored solutions.

What is the STERIS plc dividend?

STERIS plc pays a dividend of 1.8 USD distributed over 4 payouts per year.

How often does STERIS plc pay dividends?

STERIS plc pays out a dividend 4 times a year.

What is the STERIS plc ISIN?

The ISIN of STERIS plc is IE00BFY8C754.

What is the STERIS plc WKN?

The WKN of STERIS plc is A2PGLV.

What is the STERIS plc ticker?

The ticker of STERIS plc is STE.

How much dividend does STERIS plc pay?

Over the past 12 months, STERIS plc paid a dividend of 1.61 USD . This corresponds to a dividend yield of about 0.66 %. For the coming 12 months, STERIS plc is expected to pay a dividend of 1.64 USD.

What is the dividend yield of STERIS plc?

The current dividend yield of STERIS plc is 0.66 %.

When does STERIS plc pay dividends?

STERIS plc pays a quarterly dividend. This is distributed in the months of December, March, July, October.

How secure is the dividend of STERIS plc?

STERIS plc paid dividends every year for the past 25 years.

What is the dividend of STERIS plc?

For the upcoming 12 months, dividends amounting to 1.64 USD are expected. This corresponds to a dividend yield of 0.67 %.

In which sector is STERIS plc located?

STERIS plc is assigned to the 'Health' sector.

Wann musste ich die Aktien von STERIS plc kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of STERIS plc from 9/20/2024 amounting to 0.57 USD, you needed to have the stock in your portfolio before the ex-date on 9/5/2024.

When did STERIS plc pay the last dividend?

The last dividend was paid out on 9/20/2024.

What was the dividend of STERIS plc in the year 2023?

In the year 2023, STERIS plc distributed 1.98 USD as dividends.

In which currency does STERIS plc pay out the dividend?

The dividends of STERIS plc are distributed in USD.

All fundamentals about STERIS plc

Our stock analysis for STERIS plc Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of STERIS plc Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.